METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT FOLLICULAR LYMPHOMA

Provided herein are methods of treating B-cell proliferative disorders (such as Follicular Lymphoma "FL") using im-munoconjugates comprising anti-CD79b antibodies in combination with an immunomodulatory agent (such as lenalidomide) and an anti-CD20 antibody (such as obinutuzumab or rituxim...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MUSICK, LISA, HIRATA, JAMIE HARUE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided herein are methods of treating B-cell proliferative disorders (such as Follicular Lymphoma "FL") using im-munoconjugates comprising anti-CD79b antibodies in combination with an immunomodulatory agent (such as lenalidomide) and an anti-CD20 antibody (such as obinutuzumab or rituximab). L'invention concerne des méthodes de traitement de troubles prolifératifs à lymphocytes B (tels que le lymphome folliculaire "FL") à l'aide d'immuno-conjugués comprenant des anticorps anti-CD79b en combinaison avec un agent immunomodulateur (comme le lénalidomide) et un anticorps anti-CD20 (comme l'obinutuzumab ou le rituximab).